P2RX7 and amyotrophic lateral sclerosis: Moreover, it is hypothesised that this mechanism may be a target of the central nervous system (CNS)-penetrant P2X7 antagonists JNJ-47965567 [22, 70] or AXX71 [56], which can slow disease progression in ALS SOD1G93A mice in a dose-dependent manner.